Business Context and Reporting Period
Company: Cardiff Oncology, Inc. (CRDF)
Filing Type: Form 8-K (Current Report)
Date of Report: June 1, 2021
Context: The filing serves as a Regulation FD disclosure to announce that the Company intends to conduct meetings with third parties to present its corporate slide presentation. The presentation is attached as Exhibit 99.1.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural disclosure regarding investor communications and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document solely addresses the dissemination of the corporate presentation.
Guidance, Outlook, and Risks
Management Commentary: The Company intends to present its corporate slide presentation to third parties.
Legal Status of Information: In accordance with General Instruction B.2 of Form 8-K, the information furnished under Item 7.01 and the attached exhibit are deemed "furnished" and not "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, this information is not subject to the liabilities of that section and shall not be deemed incorporated by reference into any other filings under the Securities Act of 1933 or the Securities Exchange Act of 1934.
Key Facts for Investor Verification
- Verify the content of the corporate presentation attached as Exhibit 99.1 for specific business updates, as the 8-K text itself contains no operational details.
- Note that the information in this filing is "furnished" rather than "filed," meaning it carries different legal liability standards than standard financial reports.
- Confirm the Company's current financial status through its most recent 10-K or 10-Q filings, as this 8-K does not contain financial metrics.